Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Victoria Lane Thomas, M.D.

Concepts (54)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Civil Rights120091320.310 Why?
Adrenergic beta-2 Receptor Agonists320161040.280 Why?
Physician's Role120099420.200 Why?
Particle Size2201616400.200 Why?
Disabled Persons1200912090.170 Why?
Adrenal Cortex Hormones3201618470.160 Why?
Anti-Asthmatic Agents220165330.120 Why?
Asthma3201659550.110 Why?
Microspheres120157770.110 Why?
Health Services Accessibility1200951330.100 Why?
Adrenergic beta-Antagonists1201612390.090 Why?
Administration, Inhalation3201611040.080 Why?
Supreme Court Decisions120091280.080 Why?
Glucocorticoids1201521070.070 Why?
Prejudice120095690.060 Why?
Stroke Volume1201649830.060 Why?
Heart Failure22016108560.050 Why?
Pulmonary Disease, Chronic Obstructive1201630380.050 Why?
Disability Evaluation1200918270.050 Why?
Beclomethasone12016380.040 Why?
Pregnenediones12016290.040 Why?
Databases, Factual3201677160.040 Why?
Muscarinic Antagonists120161370.030 Why?
Drug Therapy, Combination2201664830.030 Why?
Drug Utilization Review120162450.030 Why?
Drug Dosage Calculations120151130.030 Why?
Polypharmacy120162940.030 Why?
Bronchodilator Agents120165020.030 Why?
Delayed-Action Preparations120159650.030 Why?
Netherlands1201621700.020 Why?
Angiotensin Receptor Antagonists120169230.020 Why?
Comparative Effectiveness Research120156810.020 Why?
Angiotensin-Converting Enzyme Inhibitors1201615170.020 Why?
Cohort Studies32016404500.020 Why?
Guideline Adherence1201622660.020 Why?
Dose-Response Relationship, Drug12015109430.010 Why?
Logistic Models12016134030.010 Why?
United States12009696930.010 Why?
Primary Health Care1201645510.010 Why?
Treatment Outcome22016629660.010 Why?
Practice Guidelines as Topic1201672760.010 Why?
Disease Progression12015132560.010 Why?
Humans520167420880.010 Why?
Male420163495380.010 Why?
Female420163795920.010 Why?
Time Factors12016400540.010 Why?
Follow-Up Studies12015390040.010 Why?
Child, Preschool12015409550.010 Why?
Middle Aged220162131270.010 Why?
Adult220162137120.010 Why?
Aged, 80 and over12016576830.010 Why?
Retrospective Studies12016770980.000 Why?
Child12015774780.000 Why?
Aged120161629440.000 Why?
Thomas's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (54)
Explore
_
Co-Authors (2)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.